Joaquin Nicolas Jadue Musalem - 10 Aug 2026 Form 4 Insider Report for Ticketplus Ltd. (TP)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Aug 2026, 17:28:53 UTC
Prior SEC filing
06 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joaquin Nicolas Jadue Musalem

Key filing fact

Joaquin Nicolas Jadue Musalem filed Form 4 for Ticketplus Ltd. (TP) on 10 Aug 2026.

Key facts

  • This page summarizes Joaquin Nicolas Jadue Musalem's Form 4 filing for Ticketplus Ltd. (TP).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 10 Aug 2026, 17:28.

Change

  • Previous filing in this sequence was filed on 06 Aug 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002103559 Primary reporting owner

Jadue Musalem Joaquin Nicolas

Relationship
Chief Financial Officer
Address
C/O TICKETPLUS LTD. ALONSO DE CORDOVA, 5320, PISO 16, LAS CONDES, SANTIAGO, CHILE
Signature
/s/ Joaquin Nicolas Jadue Musalem
Signature date
10 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TP transaction

Ordinary Shares

Award

Transaction value
Shares
+153,846
Change %
Price
$0.000000*
Shares after
153,846
Date
10 Aug 2026
Ownership
By Medistat SpA
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reporting person is the general manager of Medistat SpA and has sole voting and dispositive power over the shares held by Medistat SpA.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .